Table 2. Detection of tenofovir in hair, plasma and peripheral blood mononuclear cells in active and placebo participant arms in the US CDC PrEP safety study.
TFV Detectable in Hair | TFV Detectable in Plasma matched to hair | TFV Detectable in Plasma matched to PBMCs | TFV Detectable in PBMCs | |||||
---|---|---|---|---|---|---|---|---|
No | Yes | No | Yes | No | Yes | No | Yes | |
Treatment | 1 | 46 | 1 | 46 | 3 | 44 | 3 | 44 |
Placebo | 40 | 1* | 40 | 1* | 10 | 1* | 10 | 1* |
TFV = tenofovir; PBMC = peripheral blood mononuclear cells;
*tenofovir detected in the same individual, on the same date, in the placebo arm across all three biomatrices